Pharmacometrics: A Quantitative Decision-Making Tool in Drug Development

Yan Xu () and Holly Kimko
Additional contact information
Yan Xu: Janssen Research and Development LLC.
Holly Kimko: Janssen Research and Development LLC.

Chapter Chapter 2 in Quantitative Methods in Pharmaceutical Research and Development, 2020, pp 71-104 from Springer

Abstract: Abstract Pharmacometrics—pharmacokinetics/pharmacodynamics (PK/PD) modeling and simulation—has been used to inform drug development decisions for more than two decades and has gained increasing support from the pharmaceutical industry, academia, and regulatory agencies. With the regulatory encouragement on model-informed drug development and the recognition of high-impact emerging applications, pharmacometric analysis currently plays an important role throughout a drug’s life cycle, from the early translational stage to the confirmatory phase 3 and regulatory approval, and even into the post-marketing trials. This chapter provides a brief introduction to pharmacometric analysis approaches including pharmacokinetic models, PK/PD models, physiologically based pharmacokinetic models, quantitative systems pharmacology models, and model based meta-analysis models. Aspects of model development are also discussed such as software, modeling work flow, and major model components, with a focus on population modeling analysis. Finally, case studies are provided to highlight the broad applications of this evolving science in drug development.

Keywords: Pharmacometrics; Model-based drug development; Pharmacokinetics/pharmacodynamics (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-030-48555-9_2

Ordering information: This item can be ordered from
http://www.springer.com/9783030485559

DOI: 10.1007/978-3-030-48555-9_2

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().